Articles by Timothy Nugent - Pharmaceutical Executive

ADVERTISEMENT

Articles by Timothy Nugent

Risky Business

Accurate and ethical price reporting is a compulsory, albeit confusing, practice for pharmaceutical manufacturers.
Apr 1, 2005

Every quarter, pharmaceutical manufacturers confront a dizzying array of price reporting obligations. Participation in the Medicare, Medicaid, Veterans Administration (VA), and Public Health Service (PHS) programs requires manufacturers to collect, organize, distill and manipulate vast quantities of information, and to generate from that data reportable figures that can have an enormous impact on the company's bottom line. It is critical that these figures be correct, not only to help ensure the integrity of these public programs, but because submission of false data to a federal agency is a prosecutable criminal offense, and the civil penalties and exposure can be staggering.

ADVERTISEMENT

Click here